Progressive massive fibrosis: An overview of the recent literature

David N Weissman1

  • 1National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, United States of America.

Insights

Progressive massive fibrosis (PMF) is linked to silica exposure in coal miners and artificial stone workers. Current treatments are lacking, highlighting an urgent need for new therapies to prevent and manage this severe lung disease.

Area of Science:

  • Occupational Medicine
  • Pulmonary Medicine
  • Toxicology

Background:

  • Progressive massive fibrosis (PMF) is a severe lung disease linked to dust exposure.
  • Understanding PMF's pathophysiology and epidemiology is crucial for developing effective interventions.
  • Current literature lacks comprehensive reviews on recent PMF advancements.

Purpose of the Study:

  • To review recent literature on progressive massive fibrosis (PMF) from 2009 to present.
  • To summarize advances in PMF pathophysiology, epidemiology, and clinical impact.
  • To identify gaps in knowledge and unmet needs in PMF prevention and treatment.

Main Methods:

  • Comprehensive literature review of studies published from September 2009 to the present.
  • Analysis of research on PMF etiology, progression, and diagnostic imaging.
  • Evaluation of epidemiological data on dust-exposed workers and PMF development.

Main Results:

  • Silica in coal mine dust and artificial stone dust is strongly implicated in causing PMF.
  • PMF significantly impairs pulmonary function compared to less severe pneumoconiosis.
  • Computed tomography (CT) shows higher sensitivity for PMF detection than chest X-ray; MRI shows potential for differentiating PMF from lung cancer.

Conclusions:

  • PMF development is associated with silica exposure and increased dust exposure.
  • While PMF can occur without prior small opacity pneumoconiosis, its presence increases risk.
  • There is a critical need for novel therapies to prevent and treat progressive massive fibrosis.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
357
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.2K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
280
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.0K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.8K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
501